Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States
2018 · Advances in Therapy · 24 citations
https://doi.org/10.1007/s12325-018-0840-8
C
Christine L. Baker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
1.9K
Citations
20
h-index
33
i10-index
Christine L. Baker is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Smoking Behavior and Cessation & Chronic Obstructive Pulmonary Disease (COPD) Research & Atrial Fibrillation Management and Outcomes. The author has an h-index of 20, co-authored 81 publications.
ORCID: 0000-0001-7532-7399Papers by this author
worksA cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
2018 · ClinicoEconomics and Outcomes Research · 22 citations
https://doi.org/10.2147/ceor.s165576
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
2019 · Journal of Thrombosis and Thrombolysis · 16 citations
https://doi.org/10.1007/s11239-019-01838-5
Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials
2022 · Orphanet Journal of Rare Diseases · 9 citations
https://doi.org/10.1186/s13023-022-02333-6
Content Validity of a Willingness to Quit Tool for Use with Current Smokers in Clinical Practice
2017 · Advances in Therapy · 4 citations
https://doi.org/10.1007/s12325-017-0611-y
Development of a Conceptual Model for the Patient Experience of Focal Segmental Glomerulosclerosis (FSGS): A Qualitative Targeted Literature Review
2023 · Advances in Therapy · 3 citations
https://doi.org/10.1007/s12325-023-02651-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat